New York, US, March 10, 2023 (GLOBE NEWSWIRE) -- A global Healthcare business-consulting firm, Maximize Market research, has published a market intelligence and competitive landscape report on the “In-Vitro Diagnostics Market”. The report is a combination of primary and secondary data and domain experts have analyzed the In-Vitro Diagnostics Market from a regional and a global perspective. Over the forecast period, Maximize Market research expects, the market to grow from USD 98.5 Bn in 2021 to USD 128.8 Bn in 2029 at a CAGR of 3.41 percent. As per the report, the North America region is expected to dominate the global In-Vitro Diagnostics Market during the forecast period.
In-Vitro Diagnostics Market Report Scope and Research Methodology
| Market Size in 2021 | USD 98.5 Bn. |
| Market Size in 2029 | USD 128.8 Bn. |
| CAGR | 3.41 percent (2022-2029) |
| Forecast Period | 2022-2029 |
| Base Year | 2021 |
| Number of Pages | 267 |
| No. of Tables | 115 |
| No. of Charts and Figures | 113 |
| Segment Covered | Product And Services, Technology, Application and End-User |
| Regional Scope | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Report Coverage | Market Share, Size & Forecast by Revenue | 2022−2029, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis. |
Request For Free Sample Report: https://www.maximizemarketresearch.com/request-sample/362
The In-Vitro Diagnostics report provides a thorough analysis of market size, price, demand, mergers and acquisitions, supply chain, investment and expansion plans by key competitors, and predictions. The In-Vitro Diagnostics Market potential is assessed through detailed analysis and segmentation. The analysis provides investors with a full insight into the In-Vitro Diagnostics industry's future, as well as the elements that are expected to affect the market positively and negatively. The report presents through analysis of the major competitors, including market leaders, followers, and new entrants with every important aspect of the In-Vitro Diagnostics Market. The report includes strategic profiles of the key market participants, a full examination of their key competencies and their company-specific plans for the introduction of new products, partnerships, growth, joint ventures, and acquisitions. The bottom-up approach was used to estimate the regional and global In-Vitro Diagnostics Market size. Both the research methods, primary and secondary were employed to collect the data for the In-Vitro Diagnostics Market report. To provide the strengths and weaknesses of the Vitro Diagnostics industry, the SWOT analysis was used. PESTLE was employed to present the potential impact of the macro-economic and micro-economic factors affecting the market and thus, the report provides a detailed overview of the Vitro Diagnostics industry.
In-Vitro Diagnostics Market Overview
In-Vitro Diagnostics (IVD) are the tests that are used to diagnose diseases and infections, monitor drug therapies and diagnose medical conditions. Such tests are carried out on samples including blood, tissues and urine. The development of condition-specific markers and tests is the factor that is expected to provide the In-Vitro Diagnostics Market growth opportunities during the forecast period.
In-Vitro Diagnostics Market Dynamics
During the forecast period, the increasing research and development are expected to create new growth opportunities for the In-Vitro Diagnostics Market growth. The increasing geriatric population and rising knowledge regarding early testing resulted in a rise in the number of check-ups, which in turn contributes to the In-Vitro Diagnostics Market growth. The demand for In-Vitro Diagnostics tests is also expected to increase during the forecast period due to the increasing adoption of Point-of-Care testing devices. However, the market growth is expected to be hampered due to the high cost of In-Vitro Diagnostics instruments.
Get the Sample PDF of the Report: https://www.maximizemarketresearch.com/request-sample/362
In-Vitro Diagnostics Market Regional Insights
In 2021, the North America region dominated the global market by holding around 38 percent of the In-Vitro Diagnostics Market share. This dominance is majorly due to favourable government regulations and increasing adoption of technologically advanced diagnostic techniques.
The In-Vitro Diagnostics Market in the Asia Pacific region is expected to grow at a high CAGR, especially in developing countries such as China, India, Australia and South Korea. The In-Vitro Diagnostics Market growth is expected majorly due to the increasing per capita healthcare expenditure in the region.
In-Vitro Diagnostics Market Segmentation
By Product And Services
- Reagents
- Instruments
- Software And Services
By Technique
- Immunodiagnostics
- Hematology
- Molecular Diagnostics
- Tissue Diagnostics
- Clinical Chemistry
- Others
By Application
- Infectious Diseases
- Cancer
- Cardiac Diseases
- Immune System Disorders
- Nephrological Diseases
- Gastrointestinal Diseases
- Others
By End-User
- Standalone Laboratories
- Hospitals
- Academic And Medical Schools
- Point Of Care
- Others
Get Customization on this Report for Specific Research Solutions: https://www.maximizemarketresearch.com/request-customization/362
In-Vitro Diagnostics Market Key Competitors include:
- Danaher Corporation (US)
- Carlyle Investment Management L.L.C. (US)
- Beckman Coulter (US)
- Alere, Inc. (US)
- Ortho Clinical Diagnostics (US)
- Agilent Technologies (US)
- Bio-Rad Laboratories (US)
- Becton, Dickinson, and Company (US)
- Thermo Fisher Scientific Inc. (US)
- Abbott (US)
- Johnson & Johnson (US)
- QIAGEN (Germany)
- Siemens AG (Germany)
- Roche Diagnostics (Switzerland)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BioMérieux SA (France)
- DiaSorin (Italy)
- Sysmex Corporation (Japan)
- Arkray (Japan)
Key questions answered in the In Vitro Diagnostics Market are:
- What is the growth potential of the In Vitro Diagnostics Market?
- What was the In Vitro Diagnostics Market size in 2021?
- Which segment held the largest In Vitro Diagnostics Market share in 2021?
- What is the CAGR of the In Vitro Diagnostics Market?
- What are the global trends in the In Vitro Diagnostics Market?
- What are the recent industry trends that can be implemented to generate additional revenue streams for In Vitro Diagnostics Market?
- What growth strategies are the players considering to increase their presence in the In Vitro Diagnostics Market?
- Who are the leading companies and what are their portfolios in In Vitro Diagnostics Market?
- What are the major challenges that the In Vitro Diagnostics Market could face in the future?
- Who held the largest market share in In Vitro Diagnostics Market?
Get a Sample Copy of the Report: https://www.maximizemarketresearch.com/request-sample/362
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2021)
- Past Pricing and price curve by region (2018 to 2021)
- Market Size, Share, Size & Forecast by different segment | 2022−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Market Segmentation – A detailed analysis by Product And Services, Technology, Application End-User and Region
- Competitive Landscape – Profiles of selected key players by region in a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
In-vitro Toxicology Testing Market - The market size is expected to reach USD 21.98 billion by 2029 at a CAGR of 10.10 percent during the forecast period. The market is expected to be driven by increasing socio-ethical concerns for animal testing and increasing demand for faster testing and research conducted in the healthcare sector.
Respiratory Diagnostics Market - The market size is expected to reach USD 13.91 billion by 2029 at a CAGR of 7.3 percent during the forecast period. The market is expected to be driven by growing advances in technological investment and in-vitro diagnostic tests with the new generation.
Immunoassay Market - The market size is expected to reach USD 47.11 billion by 2029 at a CAGR of 6.50 percent during the forecast period. The market is expected to be driven by its use in many important areas of pharmaceutical analysis such as diagnosis of diseases, clinical pharmacokinetics, therapeutic drug monitoring and bioequivalence studies in drug discovery and pharmaceutical industries.
Cancer Diagnostics Market - The market size is expected to reach USD 46.45 billion by 2029 at a CAGR of 11.6 percent during the forecast period. The market is expected to be driven by increasing public awareness and supportive public measures.
Clinical Diagnostics Market - The market size is expected to reach USD 115.8 billion by 2029 at a 6.5 CAGR of percent during the forecast period. The market is expected to be driven by the increasing demand for disease detection and increasing expenditure in the healthcare sector.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
